32,795 Shares of The Pennant Group, Inc. $PNTG Bought by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. bought a new stake in The Pennant Group, Inc. (NASDAQ:PNTG) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 32,795 shares of the company’s stock, valued at approximately $1,279,000. Oppenheimer & Co. Inc. owned 0.09% of The Pennant Group as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. BlackRock Inc. bought a new position in The Pennant Group during the second quarter worth about $109,340,000. Wasatch Advisors LP lifted its position in shares of The Pennant Group by 31.8% in the second quarter. Wasatch Advisors LP now owns 1,870,178 shares of the company’s stock valued at $69,103,000 after buying an additional 451,491 shares during the last quarter. Paradigm Capital Management Inc. NY acquired a new stake in shares of The Pennant Group in the second quarter valued at approximately $51,833,000. Turtle Creek Asset Management Inc. boosted its stake in shares of The Pennant Group by 12,075.6% during the 1st quarter. Turtle Creek Asset Management Inc. now owns 1,582,823 shares of the company’s stock worth $48,244,000 after acquiring an additional 1,569,823 shares during the period. Finally, Dimensional Fund Advisors LP boosted its stake in shares of The Pennant Group by 1.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 815,660 shares of the company’s stock worth $24,861,000 after acquiring an additional 11,943 shares during the period. 85.88% of the stock is owned by institutional investors.

The Pennant Group Stock Performance

Shares of PNTG stock opened at $41.66 on Monday. The Pennant Group, Inc. has a 12-month low of $22.25 and a 12-month high of $43.41. The company has a market capitalization of $1.46 billion, a PE ratio of 46.29, a price-to-earnings-growth ratio of 2.72 and a beta of 1.33. The firm has a 50 day moving average price of $39.96 and a two-hundred day moving average price of $35.41. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.48.

The Pennant Group (NASDAQ:PNTG) last posted its earnings results on Wednesday, August 5th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.33 by $0.03. The company had revenue of $297.98 million for the quarter, compared to the consensus estimate of $288.71 million. The Pennant Group had a return on equity of 10.33% and a net margin of 2.93%. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. As a group, analysts predict that The Pennant Group, Inc. will post 1.18 earnings per share for the current year.

Analyst Upgrades and Downgrades

PNTG has been the topic of a number of research analyst reports. Weiss Ratings upgraded The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, August 19th. Truist Financial raised their price target on The Pennant Group from $42.00 to $48.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Wells Fargo & Company lifted their price objective on shares of The Pennant Group from $45.00 to $46.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 11th. Finally, Royal Bank Of Canada upped their price objective on shares of The Pennant Group from $42.00 to $44.00 and gave the company an “outperform” rating in a report on Thursday, August 20th. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $46.00.

The Pennant Group Profile

The Pennant Group, Inc is a healthcare services company that operates home health, hospice and senior living businesses in the United States. Through its affiliated agencies and communities, the company provides skilled nursing, physical, occupational and speech therapy, personal care, hospice and palliative services, assisted living, and other support for older adults and individuals recovering from illness or injury.

Pennant’s home health and hospice operations serve patients in their homes and other residential settings, while its senior living segment operates communities that provide assisted living and related services.